Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04505423
Other study ID # 20-0727
Secondary ID
Status Completed
Phase
First received
Last updated
Start date August 3, 2020
Est. completion date May 1, 2021

Study information

Verified date February 2022
Source University of North Carolina, Chapel Hill
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to compare the rate and severity of complications associated with CSFD placement either with or without fluoroscopic guidance.


Description:

Patients undergoing thoracoabdominal aortic aneurysm (TAAA) repair are at risk of suffering devastating spinal cord injury (SCI), rendering them with a permanent neurologic deficit, paraplegia, or paraparesis. Despite huge success over the last several decades with the introduction of innovative protective maneuvers, such as the use of cerebrospinal fluid drains (CSFDs), the rate of these complications remains around 5%. Spinal cord perfusion can be compromised during aortic surgery and the intrathecal decompression achieved by CSFDs functions to increase the pressure gradient of blood flow, thereby optimizing spinal cord perfusion during aortic surgery. There are two methods commonly used to place cerebrospinal fluid drains: blind placement and with fluoroscopic guidance. Prior to 2016, CSFDs at UNC hospital were primarily placed without image guidance. However, hospital policy then transitioned to having all CSFDs placed using fluoroscopic guidance. To the investigators' knowledge, there are no reported studies directly comparing clinical outcomes of CSFDs placed by these methods. Given the increased cost and radiation exposure associated with the use of fluoroscopy, a better understanding of comparative outcomes has great potential clinical value. Therefore, the investigators propose to compare the rate and severity of complications associated with CSFD placement either with or without fluoroscopic guidance.


Recruitment information / eligibility

Status Completed
Enrollment 302
Est. completion date May 1, 2021
Est. primary completion date May 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - CSF drain placed from 2010 to present prior to undergoing aortic surgery Exclusion Criteria: - Patients under 18 years of age - Patients undergoing emergency procedures

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Blind CSF Drain Placement
CSF Drain placement without fluoroscopic image guidance.
Fluoroscopy-guided Drain Placement
CSF Drain placement utilizing fluoroscopic image guidance.

Locations

Country Name City State
United States UNC Chapel Hill Chapel Hill North Carolina

Sponsors (2)

Lead Sponsor Collaborator
University of North Carolina, Chapel Hill UNC Medical Alumni

Country where clinical trial is conducted

United States, 

References & Publications (2)

Safi HJ, Estrera AL, Miller CC, Huynh TT, Porat EE, Azizzadeh A, Meada R, Goodrick JS. Evolution of risk for neurologic deficit after descending and thoracoabdominal aortic repair. Ann Thorac Surg. 2005 Dec;80(6):2173-9; discussion 2179. — View Citation

Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ. Experience with 1509 patients undergoing thoracoabdominal aortic operations. J Vasc Surg. 1993 Feb;17(2):357-68; discussion 368-70. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Rate and Severity of Complications Related Associated with CSFD placement The rate and severity of complications associated with CSFD placement with or without fluoroscopic guidance via a chart review. This will be assessed using quantitative methods such as vital signs and lab-work drawn relating to the procedure as well as qualitative variables through clinical notes. From admission to discharge, up to 2 weeks